However, in other cancer types, including other hematological cancers, and epithelial ovarian cancer, SOX11 is frequently methylated and high SOX11 expression is associated with improved survival [16, 37–39]. This evidence concerns the gene SOX11 and hematopoietic and lymphoid cell neoplasm.